In this review, we analyze the possibility that YAP can also intervene in hematological neoplasms such as lymphomas, multiple myeloma, and acute and chronic leukemias, modifying the phenomena of cell proliferation and cell death. The gene discussed is YAP1; the disease is hematopoietic and lymphoid system neoplasm.